{"title":"Évaluation de la réponse des lymphomes en TDM : de CHESON à RECIL","authors":"E. de Kerviler, C. de Margerie-Mellon","doi":"10.1016/j.mednuc.2024.10.001","DOIUrl":null,"url":null,"abstract":"<div><div>In oncology, the use of standardized criteria to assess tumor response is crucial in clinical trials and routine care. Before 1999, criteria for malignant lymphomas were highly variable, complicating comparisons and assessment of treatment efficacy. This need for standardization to improve the reliability of results, particularly regarding normal lymph node size and how response is measured and assessed, led to the development of the Response Evaluation Criteria in Solid Tumors (RECIST) and Cheson criteria for lymphomas. The recent Response Evaluation Criteria in Lymphoma (RECIL), were specifically developed for the assessment of response to treatment in lymphomas, but these criteria are imperfect and the trend is to use the Lugano criteria instead.</div></div>","PeriodicalId":49841,"journal":{"name":"Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique","volume":"48 6","pages":"Pages 245-248"},"PeriodicalIF":0.2000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928125824002547","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In oncology, the use of standardized criteria to assess tumor response is crucial in clinical trials and routine care. Before 1999, criteria for malignant lymphomas were highly variable, complicating comparisons and assessment of treatment efficacy. This need for standardization to improve the reliability of results, particularly regarding normal lymph node size and how response is measured and assessed, led to the development of the Response Evaluation Criteria in Solid Tumors (RECIST) and Cheson criteria for lymphomas. The recent Response Evaluation Criteria in Lymphoma (RECIL), were specifically developed for the assessment of response to treatment in lymphomas, but these criteria are imperfect and the trend is to use the Lugano criteria instead.
期刊介绍：
Le but de Médecine nucléaire - Imagerie fonctionnelle et métabolique est de fournir une plate-forme d''échange d''informations cliniques et scientifiques pour la communauté francophone de médecine nucléaire, et de constituer une expérience pédagogique de la rédaction médicale en conformité avec les normes internationales.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
